Heparin and Streptokinase
Explore this paper's citation graph
Summary
The conundrum re_ects subtle epistemological factors pertinent to the evaluation of therapeutic interventions, the in_uence of economic as well as pharmacodynamic and pharmacokinetic considerations, confounding factors re-ecting multiple actions of drugs in diverse subsets of patients, and consequently divergent interpretations of data.
- Type
- article
- Published
- 1997-04-01
- Cited by
- 0
- References
- 28
- OpenAlex
- https://openalex.org/W9140686
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30008178
Keywords
Management, Business, Economics
References
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
- Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits.
- Is Heparin of Value in the Management of Acute Myocardial Infarction?
- Heparin After Acute Myocardial Infarction
- Coronary thrombolysis in perspective : principles underlying conjunctive and adjunctive therapy
- An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
- Coronary thrombolysis--it's worth the risk.
- Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
- Intracranial bleeding, fibrinolysis, and anticoagulation. Causal connections and clinical implications.
- Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
- Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis.
- Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
- Conjunctive anticoagulation and coronary thrombolysis
- Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
- A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis.
- Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
- Effect of Coronary Thrombus Age on Fibrinogen Uptake
- Paradoxical attenuation of fibrinolysis attributable to “plasminogen steal” and its implications for coronary thrombolysis
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
Cited by
No citing papers recorded for this paper.